Evidence map›Paper›PMID 11222420›Full record

ArticleBMJ (Clinical research ed.)2001

Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis.

J A Kaye, M del Mar Melero-Montes, H Jick

Open access · bronzeAbstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 3 pooled it
43.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 3 syntheses or guidelines pooled it, 393 citations in OpenAlex.

  1. Vaccines for measles, mumps, rubella, and varicella in children.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Vaccines for measles, mumps, rubella, and varicella in children.The Cochrane database of systematic reviews · 2020
    Pooled it
  3. Vaccines for measles, mumps and rubella in children.The Cochrane database of systematic reviews · 2012
    Pooled it
  4. Article
  5. Review
  6. Air Pollution during Pregnancy and Childhood Autism Spectrum Disorder in Taiwan.International journal of environmental research and public health · 2021
    Article
  7. Willingness to Take COVID-19 Vaccines in Ethiopia: An Instrumental Variable Probit Approach.International journal of environmental research and public health · 2021
    Article
  8. The MMR Vaccine and Autism.Annual review of virology · 2019
    Review
  9. Article
  10. Defining Phenotypes from Clinical Data to Drive Genomic Research.Annual review of biomedical data science · 2018
    Article
  11. Article
  12. The Experiences of Fathers Who Have Offspring with Autism Spectrum Disorder.Journal of autism and developmental disorders · 2017
    Article
  13. Review
  14. Brief report: autism awareness: views from a campus community.Journal of autism and developmental disorders · 2014
    Article
  15. Article
  16. Public trust and vaccine acceptance--international perspectives.Human vaccines & immunotherapeutics · 2013
    Review
  17. A secure distributed logistic regression protocol for the detection of rare adverse drug events.Journal of the American Medical Informatics Association : JAMIA · 2013
    Article
  18. Article
  19. The autism-vaccine story: fiction and deception?Canadian family physician Medecin de famille canadien · 2010
    Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

J A KayeBoston Collaborative Drug Surveillance Program, Boston University School of Medicine, 11 Muzzey Street, Lexington, MA 02421, USA. jkaye@narsil.com
M del Mar Melero-Montes
H Jick
Boston Collaborative Drug Surveillance Program · USBoston University · US

Funding

Training Program in Cancer EpidemiologyT32CA009001 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI A. Heather Eliassen, Meir Stampfer · 1985 to 2026
$17.3M
NCI NIH HHS T32 CA009001Wellcome Trust
6 · The paper itself

Abstract

objectiveTo estimate changes in the risk of autism and assess the relation of autism to the mumps, measles, and rubella (MMR) vaccine.

designTime trend analysis of data from the UK general practice research database (GPRD).

settingGeneral practices in the United Kingdom. SUBJECTS: Children aged 12 years or younger diagnosed with autism 1988-99, with further analysis of boys aged 2 to 5 years born 1988-93.

main outcome measuresAnnual and age specific incidence for first recorded diagnoses of autism (that is, when the diagnosis of autism was first recorded) in the children aged 12 years or younger; annual, birth cohort specific risk of autism diagnosed in the 2 to 5 year old boys; coverage (prevalence) of MMR vaccination in the same birth cohorts.

resultsThe incidence of newly diagnosed autism increased sevenfold, from 0.3 per 10 000 person years in 1988 to 2.1 per 10 000 person years in 1999. The peak incidence was among 3 and 4 year olds, and 83% (254/305) of cases were boys. In an annual birth cohort analysis of 114 boys born in 1988-93, the risk of autism in 2 to 5 year old boys increased nearly fourfold over time, from 8 (95% confidence interval 4 to 14) per 10 000 for boys born in 1988 to 29 (20 to 43) per 10 000 for boys born in 1993. For the same annual birth cohorts the prevalence of MMR vaccination was over 95%.

conclusionsBecause the incidence of autism among 2 to 5 year olds increased markedly among boys born in each year separately from 1988 to 1993 while MMR vaccine coverage was over 95% for successive annual birth cohorts, the data provide evidence that no correlation exists between the prevalence of MMR vaccination and the rapid increase in the risk of autism over time. The explanation for the marked increase in risk of the diagnosis of autism in the past decade remains uncertain.

Indexed as

Age DistributionAutistic DisorderChildChild, PreschoolFamily PracticeFemaleHumansIncidenceMaleMeasles-Mumps-Rubella VaccineRisk AssessmentUnited KingdomMeasles-Mumps-Rubella Vaccine

Identifiers

PMID11222420
PMCPMC26561
OpenAlexW2148194409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.